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Abstract 
Background: Data sparsity is a major limitation to estimating national and global dementia burden. Surveys with 
full diagnostic evaluations of dementia prevalence are prohibitively resource-intensive in many settings. However, 
validation samples from nationally representative surveys allow for the development of algorithms for the prediction 
of dementia prevalence nationally.
Methods: Using cognitive testing data and data on functional limitations from Wave A (2001–2003) of the ADAMS 
study (n = 744) and the 2000 wave of the HRS study (n = 6358) we estimated a two-dimensional item response theory 
model to calculate cognition and function scores for all individuals over 70. Based on diagnostic information from the 
formal clinical adjudication in ADAMS, we fit a logistic regression model for the classification of dementia status using 
cognition and function scores and applied this algorithm to the full HRS sample to calculate dementia prevalence by 
age and sex.
Results: Our algorithm had a cross-validated predictive accuracy of 88% (86–90), and an area under the curve of 0.97 
(0.97–0.98) in ADAMS. Prevalence was higher in females than males and increased over age, with a prevalence of 4% 
(3–4) in individuals 70–79, 11% (9–12) in individuals 80–89 years old, and 28% (22–35) in those 90 and older.
Conclusions: Our model had similar or better accuracy as compared to previously reviewed algorithms for the 
prediction of dementia prevalence in HRS, while utilizing more flexible methods. These methods could be more easily 
generalized and utilized to estimate dementia prevalence in other national surveys.
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Background
High-quality estimates of dementia prevalence are 
critical for informed health system planning, especially 
given the high estimated prevalence of dementia, both 
in the United States and globally. Recent estimates 
suggest that there were an estimated 4.9 (95% UI 4.4–
5.4) million individuals living with dementia in the 
United States and an estimated 51.6 (44.3–59.0) mil-
lion individuals living with dementia globally in 2019 
[1]. Policy- and decision-makers rely on these estimates 
to inform public health planning efforts and resource 
allocation decisions. One of the major limitations in the 
estimation of dementia both nationally and globally is 
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the lack of large, nationally representative surveys with 
valid data on dementia prevalence using the Diagnostic 
and Statistical Manual (DSM) definition [2, 3]. While 
the lack of nationally representative data affects esti-
mation even in high-income settings, due to the time-
consuming and costly nature of dementia assessments, 
these limitations are especially problematic in low-
income countries, where there are large data gaps and 
only few studies, mainly non-representative, exist [4, 5].
Many large-scale surveys, such as the Health and 
Retirement Survey (HRS), a nationally representa-
tive sample of older adults in the United States, do not 
include dementia diagnoses. However, the HRS and 
other similar studies conduct evaluations of cognitive 
ability and functional limitations, the two major deter-
minants of dementia status [6]. The Aging, Demograph-
ics, and Memory Study (ADAMS) sampled individuals 
from HRS and administered an intensive diagnostic 
workup culminating in an adjudicated dementia diag-
nosis [7]. A number of algorithms have been developed 
for the estimation of dementia prevalence in HRS based 
on cut-points or regression-based methods using the 
ADAMS subsample and the questions on demographic 
information, cognitive status, and daily functional limi-
tations that are included in both surveys [8–12]. This 
study aimed to improve on these methods by using 
multidimensional item response theory (IRT) methods 
to more flexibly characterize cognitive status and func-
tional limitations, potentially facilitating the use of sim-
ilar strategies in other samples.
IRT methods are used to estimate ability on an unob-
served (latent) trait [13]. While the latent trait is not 
directly observed, answers to a series of questions (items) 
are used to estimate ability (a measure of an individual’s 
score on the latent trait) conditional on a given response 
pattern. IRT methods account for variations in the dif-
ficulty in the items assessed as well as variations in the 
strength of the relationship between different items and 
the latent trait. Within the IRT framework, individu-
als who have the same sum score (count of total correct 
items) can have different estimated latent cognitive abili-
ties [14, 15].
If two different cognitive assessments have a subset 
of items in common, these items can be used to co-cal-
ibrate the scales so that all available information can be 
used and scores can be compared without sub-setting to 
common items [16]. While previous applications of IRT 
methods in epidemiology have largely focused on scoring 
individuals on a single, unidimensional construct, such 
as cognition, multidimensional IRT methods allow for 
the concurrent estimation of multiple, related traits [17]. 
The DSM criteria for dementia are based on two different 
but related latent traits: cognitive ability and functional 
(difficulty with completing daily activities) ability [18]. 
Therefore, a multidimensional analysis is required.
This study will improve on previous algorithms for 
the prediction of dementia prevalence in HRS by utiliz-
ing IRT methods to more accurately capture the cogni-
tive and functional abilities of participants. We will also 
describe the potential utility of these methods for use 
beyond the HRS and ADAMS samples, with a focus on 




The Health and Retirement Study (HRS) is a nationally 
representative, prospective cohort study of over 37,000 
individuals in the USA [6]. The study used data from the 
2000 wave of the HRS survey. We excluded individuals 
younger than 70  years old at this wave to ensure com-
parability between the HRS and ADAMS samples as 
ADAMS was restricted to those 70 and older. The sam-
ple included 6373 individuals. The HRS study used proxy 
respondents to assess cognition and function when indi-
viduals were unable to complete the survey themselves 
(n = 1090).
The 2000 wave of HRS was used (along with the 2002 
wave of HRS) as the sampling frame for the Aging, 
Demographics, and Memory study (ADAMS). ADAMS 
stratified the sampling process by age, sex, and cogni-
tive status, sampling a larger number of individuals at 
the lowest levels of cognitive performance [7]. The sam-
ple included 856 individuals. Proxy respondents for each 
participant answered questions related to the partici-
pant’s cognitive abilities and functional limitations.
At least one non-missing response to survey items 
is required for the estimation of ability on a latent trait. 
We therefore excluded participants in both HRS and 
ADAMS who did not have at least one valid response on 
questions related to either cognition or functional limi-
tations. In HRS, we excluded 5 individuals without data 
on cognition and 10 individuals without data on func-
tional limitations yielding a final sample size of 6358. In 
ADAMS, we excluded 112 individuals without informant 
reports, and therefore without a single valid response on 
questions assessing functional limitations. Individuals 
who were excluded were not significantly different from 
those included in terms of their age, gender, years of edu-
cation, or place of residence (nursing home vs. outside of 
nursing home). This exclusion led to a final sample size of 
744 individuals.
Cognitive and functional measures
HRS administered a reduced version of the Telephone 
Interview for Cognitive Status (TICS), which includes 
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immediate and delayed word recall tasks, the serial 
7  s subtraction task, questions of orientation to time, 
backwards counting, object naming, and naming the 
president and vice president [19]. These were supple-
mented with additional questions on vocabulary from 
the Wechsler Adult Intelligence Scale-revised (WAIS-R) 
vocabulary test [20]. To assess function in HRS, respond-
ents were asked a series of questions on activities of daily 
living (ADLs) and instrumental activities of daily living 
(IADLs), which are indicative not only of physical issues 
but also difficulties in daily activities that may be influ-
enced by cognition [21, 22]. When participants were 
unable to answer cognitive questions, the short form of 
Jorm’s Informant Questionnaire on Cognitive Decline in 
the Elderly (IQCODE) was assessed (n = 660) [23].
The cognitive and functional items administered in 
ADAMS additionally included the Consortium to Estab-
lish a Registry for Alzheimer’s Disease (CERAD) animal 
fluency task [24], the Mini-Mental State Examination 
(MMSE) [25], the three-trial CERAD word list [24], the 
Trail Making Test Part A and B [26], the Digit Symbol 
Substitution Test [27], and the Digit Span test [20]. A 
full table of available items in each sample is available in 
Additional File 1.
Dementia adjudication
All participants in ADAMS were evaluated by a nurse 
and neuropsychology technician in a 3–4  h structured 
interview and assessment. A team of clinicians from the 
ADAMS study, including the study geropsychiatrist, neu-
rologist, neuropsychologist, and cognitive neuroscientist, 
assigned clinical dementia diagnoses in ADAMS based 
on all information collected along with available medi-
cal records [28]. Diagnoses were based on DSM-III-R and 
DSM-IV criteria.
Statistical analysis
The overall analytic strategy used in this analysis is 
described in Fig.  1. We first calculated descriptive 
statistics to compare the HRS and ADAMS samples. We 
used IRT methods to estimate models for latent cogni-
tive and functional ability in both HRS and ADAMS. 
Items with continuous outcomes were discretized using 
ten category equal-interval discretization [29]. We col-
lapsed categories until all categories contained at least 
5% of the total sample to prevent instability.
Based on our a priori knowledge and the results of 
exploratory factor analysis models (additional details in 
Additional File 1), we selected a two-factor model and 
designated items as related to either a factor describ-
ing cognition or a factor describing physical function 
(full list in Additional File 1). We then estimated a mul-
tiple group two-factor IRT model using the ADAMS 
and HRS samples, allowing for correlation between 
the two factors. Within the IRT model, binary items 
were modelled using two-parameter logistic regression 
models, and ordered polytomous items were modelled 
using graded-response models [30]. In IRT models, 
individual records are assumed to be independent of 
each other. Therefore, individuals appearing in both the 
HRS 2000 wave and the ADAMS sample were excluded 
from the HRS sample in this model (n = 773) to ensure 
that only one record per individual was retained in the 
final model. Item parameters (loadings and thresh-
olds) were estimated using maximum likelihood, and 
parameter values on items that were shared between 
the samples were constrained to be equal. Item load-
ings are a measure of the relationship between the 
item and the underlying latent trait on a scale of 0–1, 
whereas item thresholds indicate the ability level at 
which 50% of individuals correctly answered a binary 
item or endorsed a given response option for an ordi-
nal item. We excluded items with loadings of less than 
0.3, as this indicates a poor relationship with the under-
lying latent factor (n = 3 items). We calculated omega 
as a measure of the internal reliability of each of the 
factors estimated in our multidimensional IRT model 
using previously described methods [31]. Based on this 
Fig. 1 Flowchart for the estimation procedure. Data from the Health and Retirement Study (HRS) and the Aging, Demographics, and Memory 
study (ADAMS) are used in a multidimensional item response theory model to calculate factor scores of cognition and function. These factor scores, 
together with demographic information are then utilized in a logistic regression model to predict dementia status. This algorithm is then used to 
assess prevalence in HRS and model accuracy is assessed using ADAMS
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model, we estimated factor scores for all participants in 
the two samples.
We then estimated three weighted logistic regression 
models to predict dementia status in the ADAMS sam-
ple accounting for the complex survey design. Our first 
model (base model) included only age and sex as predic-
tors of dementia status, whereas the second model (factor 
score model) included only the factor scores for cogni-
tion and function. The final model (full model) included 
age and sex as well as the two factor scores. We com-
pared models using the Akaike Information Criterion 
(AIC) and likelihood ratio tests and tested model calibra-
tion using the Hosmer–Lemeshow goodness of fit test. 
We evaluated model discrimination and performance 
using ten-fold cross validation in the ADAMS sample, 
and we calculated cross-validated area under the curve 
(AUC), sensitivity, specificity, and accuracy, defined as 
the proportion of individuals who were correctly classi-
fied. To derive 95% uncertainty intervals around model 
performance metrics, we sampled 1000 draws of pre-
dictions from our logistic regression model, accounting 
for uncertainty in the estimated model parameters. We 
then calculated performance metrics for each draw and 
then defined the 95% confidence interval as the 25th and 
975th value of the ordered draw.
We then used the full model to predict dementia status 
in HRS, defining dementia as having a predicted prob-
ability greater than 0.5. To estimate dementia prevalence 
in HRS, we used survey weights to calculate weighted 
means and estimated confidence intervals accounting for 
the complex survey design and the variance in the sam-
pling strategy. Statistical analysis was conducted in R, 
and IRT models were estimated using the mirt package 
[32]. R code is available via https:// github. com/ ihmeuw.
Results
Sample characteristics
The ADAMS and HRS samples both included more 
women than men; however, the ADAMS sample was 
slightly older (mean age in years; standard deviation 
[SD]: 81.5; 7.1) than the HRS sample (77.8; 5.8). ADAMS 
oversampled individuals with higher levels of cognitive 
impairment, and this is reflected in the lower scores on 
the TICS cognitive assessment, higher mean number of 
ADL limitations, and lower levels of education as com-
pared to the HRS sample (Table 1).
IRT harmonization model
The estimated reliability coefficients for the cognition 
and functional limitations factors based on the mul-
tiple-group two-factor IRT model were 0.52 and 0.86 
respectively. This indicates good reliability for the func-
tion scale, but points to the existence of some remaining 
unexplained variation in the items included in the cogni-
tion factor.
The estimated loadings among the cognitive items 
ranged from 0.34 to 0.88. The items with the high-
est loadings were the MMSE items for naming a wrist-
watch, pencil, and the current year as well as the Digit 
Symbol Substitution Test. The loadings for the items 
assessing functional limitations were on average higher, 
ranging from 0.70  to 0.93. The items with the highest 
loadings were from the IQCODE proxy questionnaire 
and included the questions about whether the individual 
knew how to work familiar machines, and knew how to 
handle money and shop (Fig. 2; Panel A).
The estimated thresholds for cognition ranged 
from − 3.1 to 6.7 logits (on the scale of the latent trait) 
and covered the range of estimated factor scores for 
cognition (estimates of cognitive ability). There were a 
larger number of thresholds below the mean of the dis-
tribution of cognition factor scores, indicating that the 
questions administered were better able to precisely esti-
mate cognition for individuals with lower levels of cog-
nitive ability. The distribution of estimated thresholds 
for functional limitations was bimodal. Items assessing 
ADLs, IADLs, and informant reports of whether indi-
viduals declined versus retained the ability to perform a 
task as compared to two years ago had estimated thresh-
olds between − 1.81 and − 0.76 logits. The second mode 
of thresholds spanned 1.39–1.87 logits and consisted of 
the informant report thresholds for whether participants 
improved over the last two years on everyday tasks. These 
thresholds correspond to a higher ability level because 
improving function is more difficult than preventing 
functional decline. The distribution of ability estimates 
Table 1 Study characteristics comparing the Health and 
Retirement Survey (HRS) with the Aging, Demographics and 
Memory Study (ADAMS)
SD standard deviation, HS high school, TICS telephone Interview for cognitive 
status (score 0–10, with 10 being highest cognition), ADL activities of daily living 
(score 0–6, with 6 being needs the most help)
HRS (N = 6358) ADAMS (N = 744)
Age: 70–79—% 70.6 46.8
Age: 80–89—% 26.6 42.1
Age: 90 + —% 2.8 11.2
Education (Less than HS)—% 34.3 50.7
Education (HS)—% 33.8 24.1
Education (More than HS)—% 31.9 25.3
Sex (Female)—% 58.2 57.9
Nursing home status (Yes)—% 0.3 9.7
TICS score—mean (SD) 9.3 (1.2) 6.8 (3.3)
Number of ADL limitations—
mean (SD)
0.7 (1.3) 1.5 (2.2)
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was left-skewed, indicating that while a substantial pro-
portion of the population did not have functional limita-
tions, a smaller subset had a larger burden of functional 
limitations (Fig. 2; Panel B).
Dementia prevalence prediction
The base model, predicting dementia status based on only 
age and sex, indicated that for each additional year of age, 
the odds of having dementia increased by 17% (95% UI 
13–21). The factor score model indicated that the cogni-
tion and functional limitations each strongly predicted 
dementia status. For each unit increase in latent cognitive 
ability (a unit is one standard deviation of ability in the 
ADAMS sample), there was a 97% (94–98) reduction in 
the odds of having dementia, and for each unit increase 
in latent functional ability, there was a 57% (13–79) 
reduction in the odds of having dementia. When adjust-
ing for age and sex in the full model, the coefficient esti-
mates for the factor scores did not substantially change. 
However, the effect size for age was greatly diminished. 
AIC was lowest for the model that only included factor 
scores, and a likelihood ratio test of nested models indi-
cated that age and sex did not improve the model once 
the cognitive and functional ability were accounted for 
(Table 2). However, we retained age and sex in our final 
model, because of their biological link to dementia status. 
The Hosmer–Lemeshow goodness of fit test indicated 
good calibration (P = 0.48) and the cross-validated area 
under the curve for this final model was 0.97 (0.97–0.98), 
indicating excellent discrimination. Based on ten-fold 
cross-validation in the ADAMS sample, the sensitivity of 
predictions from this model was 84% (80–87), the speci-
ficity of the predictions was 90% (88–92), and the overall 
predictive accuracy of the model was 88% (86–90).
The distributions of factor scores by dementia status 
were similar whether classifying dementia based on true 
dementia status or predicted dementia status, indicat-
ing that the algorithm correctly classified most individu-
als. The distributions of estimated cognitive ability in the 
HRS sample were largely non-overlapping when compar-
ing those classified as having versus not having demen-
tia, indicating that the algorithm discriminates strongly 
Fig. 2 Distribution of parameters from the multidimensional item 
response theory model linking estimates of latent cognitive and 
functional ability in the Health and Retirement Study (HRS) and the 
Aging, Demographics, and Memory study (ADAMS). Panel (A) shows 
the distribution of item loadings. The item loadings indicate the 
strength of the relationship between each item and the latent trait 
on a scale of 0–1. Panel (B) shows the distribution of item thresholds 
and the density distribution of estimated individual-level latent 
cognitive and functional abilities from the two samples overlaid in 
blue. Thresholds indicate either the difficulty of a binary item or the 
difficulty of scoring one category higher on an ordinal item. A higher 
number of thresholds at a given estimated ability level indicates 
higher precision for the estimation of the latent trait at that ability 
level
Table 2 Odds ratios for the classification of dementia status in the Aging, Demographics, and Memory study (ADAMS)
Odds ratios are from logistic regression models, Intervals represent 95% confidence intervals
AIC alkaike information criterion
Base model Factor score model Full model
Age (per year) 1.17 (1.13–1.21) 1.02 (0.97–1.07)
Sex (female vs. male) 1.33 (0.83–2.14) 1.37 (0.61–3.07)
Cognition factor (per SD) 0.03 (0.02–0.06) 0.03 (0.02–0.06)
Functional limitations factor (per SD) 0.43 (0.21–0.87) 0.46 (0.23–0.92)
AIC 389.705 129.815 133.16
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on cognitive status. The overlap in the distributions was 
greater for functional ability as compared to cognition, 
due to the lack of specificity of general functional loss 
(Fig. 3).
Based on the results of this model and factor scores 
estimated from the HRS sample, we estimated that the 
overall prevalence of dementia in the United States over 
the age of 70 was 7% (95% UI 6–7). The prevalence was 
higher in females than males, and prevalence increased 
with age, with an estimated prevalence of 4% (3–4) in 
individuals 70–79  years old, 11% (9–12) in individuals 
80–89 years old, and 28% (22–35) in individuals 90 years 
old and older (Fig. 4).
Discussion
Our algorithm had good discrimination for the classifi-
cation of dementia status, with an area under the curve 
of 0.97 (95% UI 0.97–0.98). The model correctly classi-
fied 88% (86–90) of individuals in ADAMS, and based on 
the application of this model to the HRS sample, we pre-
dicted that in 2000, the prevalence of dementia over age 
70 was 7% (95% UI 6–7).
In our algorithmic logistic regression models, the 
strong and significant effect of age was highly attenu-
ated after accounting for cognition and functional 
limitations. This suggests that the effect of age was 
explained by the observed variation in cognition and 
functional limitations. Although the effect of female sex 
was not statistically significant, our models suggested a 
higher odds of dementia in women compared to men 
and the estimated effect size  was similar to what has 
been previously reported in ADAMS [33].
Compared to the five algorithms reviewed in Gian-
attasio and colleagues (2019) and evaluated using vali-
dation data, our algorithm had the highest sensitivity, 
the fourth highest specificity, and the highest AUC of 
the regression-based algorithms [34]. Our algorithm 
had the same accuracy as the top-performing algo-
rithm reviewed (the Hurd et  al. algorithm, accuracy: 
88%; 85–91), but this algorithm requires data on cogni-
tion from a previous wave of HRS, whereas our algo-
rithm leverages only cross-sectional data, increasing its 
potential applications to settings where no longitudi-
nal data are available [10, 34]. More recent algorithms 
developed with ADAMS data for use in the HRS have 
been shown to have similar performance as compared 
our algorithm in terms of sensitivity, specificity and 
accuracy [35]. However, our IRT-based algorithm pro-
vides a more flexible framework for algorithm develop-
ment that can be leveraged to estimate prevalence in 
other aging surveys.
Fig. 3 The distributions of latent cognitive and functional ability by 
dementia status in the Aging, Demographics, and Memory study 
(ADAMS) and the Health and Retirement Survey (HRS). The three 
plots show three different forms of dementia status: ADAMS true 
prevalence refers to dementia status based on the adjudicated 
clinician-based assessment, ADAMS predicted prevalence refers to 
dementia status in ADAMS based on the item response theory (IRT) 
algorithmic approach, and HRS predicted prevalence refers to the 
results of the IRT algorithmic approach in HRS
Fig. 4 Predictions of dementia prevalence in the United States in 
2000 by age and sex. These estimates were based on the application 
of the model developed in ADAMS to the Health and Retirement 
Study (HRS)
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Compared to prevalence estimates from previously 
derived algorithms, the HRS prevalence estimates by 
age group derived from our algorithm (70–79 years old: 
4%; 3–4, 80–89 years old: 11%; 9–12, 90+ years old: 28%; 
22–35) are higher than those calculated using the Her-
zog-Wallace cutoffs (70–79  years old: 2%, 80–89  years 
old: 8%, 90+ years old: 16%) but lower than those cal-
culated using the Langa-Weir cutoffs (70–79  years old: 
8%, 80–89 years old: 20%, 90+ years old: 45%) [9]. When 
compared to other studies, our age-specific estimates 
are higher than what has been observed in the Framing-
ham Heart Study (70–79 years old: 3%, 80–93 years old: 
16%); but lower than what has been observed in the Ath-
erosclerosis Risk in Communities Study (70–74  years 
old: 5%, 75–79  years old: 9%, 80–84  years old: 15%, 
85–89  years old: 25%); differences between these esti-
mates and estimates from cohort studies could be due 
to a number of factors including differences between the 
population under study and the US population as a whole 
[36, 37]. Our estimates are similar to what has been pre-
viously reported based on 2008 Medicare records (65–
74  years old: 3%, 75–84  years old: 10%; 85+ years old: 
25%) but lower than what was previously reported based 
only on the ADAMS subsample (70–79  years old: 5%, 
80–89 years old: 24%; 9–12, 90+ years old: 37%; 22–35) 
[33, 38]. However, the estimates from the ADAMS sam-
ple may be biased due to the low response rate (56%) if 
the estimated survey weights were unable to fully correct 
for the patterns of non-response observed [28].
There were a number of limitations to this work. First, 
in ADAMS, all items on functional limitations were asked 
of a proxy informant, whereas items on ADLs and IADLs 
in HRS were administered to a proxy respondent only if 
the participant was unable to be interviewed. To harmo-
nize the data on functional limitations, we assumed there 
would not be differences in response patterns of respond-
ents and proxy respondents for individuals who did not 
have a proxy respondent in HRS as well as individuals in 
ADAMS who would not have needed a proxy respond-
ent had they completed the HRS survey at that time. 
Previous evidence has suggested reasonable concord-
ance between proxy-reported and self-reported activi-
ties of daily living [39, 40]. Second, while IRT methods 
allow for the inclusion of individuals with some missing 
data, we assume that among individuals who were able to 
complete at least some of the cognitive testing, items are 
missing at random [41]. However, this assumption would 
be violated if individuals were more likely to have missing 
data on the cognitive tests that were most difficult. Third, 
differences between the ADAMS and HRS samples 
could influence the performance of our algorithm, which 
we developed using the ADAMS sample but applied to 
the HRS sample. Although ADAMS participants were 
sampled from HRS, they were on average older and less 
well educated compared to the full HRS sample. Third, 
the response rate among individuals selected for the 
ADAMS sample was 56%, and this selection bias may 
have affected algorithm development. Although we were 
unable to validate our algorithm in the HRS, future work 
linking HRS participants with another source of informa-
tion such as medical claims data would help validate the 
performance of the algorithm in the HRS sample. Fourth, 
this algorithm was developed for the purposes of overall 
prevalence estimation without regard to potential dis-
crepancies by subgroups such as racial and ethnic catego-
ries. As previous work has identified biases in algorithms 
by racial and ethnic subgroups, this algorithm should 
not be applied to the study of racial subgroups without 
further modification [34]. Additionally, changes in the 
racial and ethnic composition of the US population over 
time may influence algorithm performance in more mod-
ern samples without algorithm re-calibration. While the 
ADAMS sample is a great resource for algorithm devel-
opment, the sample is now 20  years old. However, the 
methodology developed could be used to re-calibrate the 
algorithm given a more current data source.
Although this algorithm is more complex than those 
previously developed, it is not reliant on having complete 
overlap in the items assessing cognition and function. 
Instead, all available items in both surveys can be utilized, 
provided there is sufficient overlap to “anchor” the scale 
and link scores between samples. Extending beyond the 
HRS sample, if a survey in another country had sufficient 
overlap with ADAMS on items assessing cognition and 
function, the ADAMS sample and the methods utilized 
here could be leveraged to provide prevalence estimates 
for surveys in other locations [14]. A number of coun-
tries (e.g., South Africa) do not have formal evaluations 
of dementia prevalence available but have conducted 
broader surveys which include evaluations of cogni-
tion and functional limitations [42]. The application of 
these methods to available surveys could therefore help 
address issues of data sparsity in the global modelling 
of dementia prevalence. The simplicity of the proposed 
algorithm, which only includes basic demographic vari-
ables in addition to cognition and functional limitations, 
facilitates the potential generalization of this method to 
the estimation of prevalence in other geographic settings. 
By improving data coverage and the quality of global esti-
mates for dementia prevalence, decision-makers and pol-
icy-makers will be able to make better evidence-driven 
decisions around resource allocation and funding.
However, when harmonizing measures of cognition 
and function in the ADAMS sample with samples out-
side of the United Sates, it will be important to consider 
potential implications of differential item functioning 
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(DIF), or differences across cultural contexts in esti-
mated item parameters. Prior work showing evidence of 
DIF in cognitive items by demographic characteristics 
suggests that differences in cultural contexts will likely 
lead to some DIF, which could result in biased compari-
sons between samples. However, if some common items 
without evidence of DIF can be identified, models can 
be adjusted to account for DIF [43–45]. Use of smaller 
validation samples nested in larger surveys, such as the 
proposed validation sample to be conducted within the 
Longitudinal Aging Study in India, would allow for con-
text-specific algorithm calibration and would circumnav-
igate potential concerns about DIF [46].
Conclusions
In summary, we used multidimensional IRT-based meth-
ods to predict prevalence in the HRS sample. Compared 
to previous algorithms, our model had similar or better 
accuracy in the ADAMS sample. Furthermore, because 
the algorithm only relies on having a subset of items in 
common with a validation sample, this strategy could 
potentially be extended to other contexts. By improving 
the overall accuracy of predictive algorithms and poten-
tially allowing researchers to leverage new data sources, 
this algorithmic strategy could serve to strengthen 
national and global estimates of dementia and improve 
the evidence on which policy-makers can base important 
decisions surrounding public health planning efforts and 
the resource allocation.
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